New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
The plant has a capacity for extraction of 2500 mt of poppy straw and 300 mt poppy gum per year
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
Glenmark's current portfolio consists of 188 products authorized for distribution in the US
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
Lupin enters into BTA with Lupin Manufacturing Solutions
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
Lupin is exclusive first-to-file and may be eligible to receive a 180-day exclusivity period at product launch
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
Subscribe To Our Newsletter & Stay Updated
